Natural disasters (hurricanes, floods, earthquakes and volcanic eruptions) can contribute to the transmission of some diseases provided the causative agent is already in the environment. Rapid changes in the human environment may occur also as a result of acts of war or of other man made circumstances including major industrial accident
Latin American countries have a long experience in the prevention and control of vector-borne diseases. Therefore, it is safe to assume that in areas where important vector-borne diseases are endemic the health departments have control activities in operation. This implies (a) availability of baseline data; (b) the existence of a core group of epidemiologists, entomologists and public health specialists who can advise on measures to be taken; (c) availability of equipment, manuals and training material; and (d) logistic support and emergency supplies.
When disasters hit disease transmission risk factors increase, vector control activities are disrupted and pre-existing emergency plans must become operational. Experts have noted that the majority of these plans are too rigid and should be adapted to local circumstances. The optimum use of available resources should always be taken into account.
In the period immediately following a hurricane, the risk of acquiring malaria, dengue or encephalitis may decrease as a result of the destruction of breeding places of the local vectors. The epidemiological situation is likely to change a few weeks later. It is necessary to watch for indirect effects of the disaster. Destruction of aqueducts will prompt the population to accumulate fresh water in temporary containers, which constitute an ideal breeding place for dengue carrying mosquitoes. Casualties resulting from earthquakes may increase the demand for blood transfusion, a risk in itself in areas where Chagas' disease is endemic. Living conditions in temporary camps increase man-vector contacts.
The density of mosquitoes considered non-vectors of disease are likely to increase shortly after a hurricane hits. Even though these mosquitoes have no medical importance, the affected population demands and should get attention to the nuisance problem.
No major communicable disease problems are normally expected in North America as a result of a disaster situation.
In Mainland Middle America, the Caribbean, and Tropical South America existing arthropod-borne diseases include malaria, mucocutaneous leishmaniasis, diffuse cutaneous leishmaniasis, visceral leishmaniasis, onchocerciasis (river blindness), American trypanosomiasis or Chagas' disease, bancroftian filariasis, dengue fever, dengue hemorrhagic fever (DHF), Venezuelan equine encephalitis, viral encephalitis, human fasciolosis, tularemia, jungle yellow fever, bartonellosis, Oroya fever, louse-borne typhus, and plague.
With the exception of Chagas'disease, the arthropod-borne diseases are not important in the countries of Temperate South America.
In the context of a natural disaster, the most important vector-borne diseases in the Americas are malaria, dengue fever and dengue hemorrhagic fever. Urban yellow fever shares the vector of dengue, but yellow fever is rarely transmitted in urban areas except during an epidemic. Besides, yellow fever is preventable by a safe and effective vaccine. No vaccine is currently available for malaria, dengue fever or DHF.
Q. Is it advisable to intervene based on the first news of the disaster received from the affected area?
No. The information may be exaggerated, misguided or unsubstantiated.
Q. Is it necessary to start vector control operations immediately following a disaster?
No. Usually there is time to evaluate the situation and plan the necessary operations.
Q. How do you define the affected area?
The operational area should include the area directly affected by the disaster and the area receiving displaced population.
Q. Are new diseases likely to appear during a disaster?
No. A disaster can contribute to the transmission of some diseases provided the causative agent is already in the environment.
Q. Is there a single, multipurpose, measure for the control of vector borne diseases?
No. Control measures have to be targeted to specific vectors of diseases. Some measures, however, have more than one beneficial effect.
Q. Is the increase in vector-breeding places the main cause of epidemics?
No. The increased man-vector contact in precarious shelters and temporary camps and the disruption of control activities may be more important causes for epidemics.
Q. Are epidemics after natural disasters predictable?
Yes. Epidemics occurring after cyclical disasters such as hurricanes can be predicted within a reasonable degree of precision and should be preventable if the health services are adequately prepared.
Q. Are there recent changes in the epidemiology of malaria?
Yes. Malaria is re-emerging in many areas. Besides, the global warming may have been an important contributing factor in the occurrence of local epidemics in highland areas.
Q. Are there PAHO/WHO publications on emergency vector control after natural disasters?
Yes. A list appears in the "suggested reading" annex.
Q. Which are the main measures for the control of vector-borne diseases?
Vaccination for the prevention of jungle yellow fever (YF); Sanitation, rodenticides and localized application of insecticides, for plague control; Housing improvement, selective use of insecticides, use of pyrethroid-impregnated fabrics (PIFs) as a complement to traditional measures for the control of Triatoma infestans vector of Chagas's disease; Protection of domestic water reservoirs, destruction of artificial water containers, selective application of larvicides or adulticides, for the control of A. aegypti mosquitoes, vectors of Dengue, DHF and urban YF; Case detection and treatment; selective use of residual insecticides; prophylaxis with chloroquine or mefloquine in areas with chloroquine resistant strains, for malaria.
Health education, community participation, modification of personal habits, repellents or barriers to diminish man-vector contact, in support of all of the above.
Note: Use of trade names is for identification only and does not imply endorsement by the Pan American Health Organization (PAHO/WHO)
Phone: (202) 974-3707